Hospital mortality, perioperative complications and hospital course of patients (N = 462)a,b
| Event . | Overall series . | PS-matched pairs . | ||||
|---|---|---|---|---|---|---|
| B-TVA (N = 345) . | R-TVA (N = 117) . | P-value . | B-TVA (N = 98) . | R-TVA (N = 98) . | P-value . | |
| In-hospital death | 26 (7.5) | 14 (12) | 0.14 | 5 (5.1) | 9 (9.2) | 0.27 |
| Stroke | 4 (1.2) | 0 | 0.36 | 3 (3.1) | 0 | 0.25 |
| Prolonged (>48 h) invasive ventilation | 64 (18.6) | 30 (25.6) | 0.1 | 18 (18.4) | 21 (21.4) | 0.59 |
| Atrial fibrillation, new-onset | 96/231c (41.6) | 21/86c (24.4) | 0.0049 | 25/66c (37.9) | 17/69c (24.6) | 0.097 |
| Transient complete atrioventricular block | 35/341d (10.3) | 20/116d (17.2) | 0.046 | 10/96d (10.4) | 14/97d (14.4) | 0.67 |
| Myocardial infarction | 1 (0.3) | 0 | 0.75 | 0 | 0 | – |
| Low cardiac outpute | 35 (10.1) | 21 (17.9) | 0.025 | 9 (9.2) | 14 (14.3) | 0.27 |
| Use of adrenergic agonists | 256 (74.2) | 91 (77.8) | 0.44 | 78 (79.6) | 73 (74.5) | 0.4 |
| Intra- and postoperative use of IABP | 7 (2) | 3 (2.6) | 0.49 | 0 | 1 (1) | 0.5 |
| Use of ECMO | 2 (0.6) | 0 | 0.56 | 0 | 0 | – |
| Acute kidney injuryf | 19 (5.5) | 12 (10.3) | 0.076 | 3 (3.1) | 7 (7.1) | 0.19 |
| Renal replacement therapy | 13 (3.8) | 8 (6.8) | 0.17 | 2 (2) | 5 (5.1) | 0.44 |
| Bleeding peptic ulcer | 1 (0.3) | 1 (0.9) | 0.44 | 0 | 0 | – |
| Mesenteric ischaemia | 3 (0.9) | 1 (0.9) | 0.73 | 1 (1) | 1 (1) | 1 |
| Acute pancreatitis | 0 | 1 (0.9) | 0.25 | 0 | 0 | – |
| Multiorgan failure | 22 (6.4) | 11 (9.4) | 0.27 | 4 (4.1) | 5 (5.1) | 1 |
| Sepsis | 8 (2.3) | 2 (1.7) | 0.51 | 1 (1) | 1 (1) | 1 |
| 48-h chest tube output, ml | 1371 ± 1510 | 1836 ± 2336 | 0.084 | 1412 ± 1552 | 1763 ± 2306 | 0.27 |
| Multiple blood transfusion (>2 RBCs) | 120 (34.8) | 33 (28.2) | 0.19 | 37 (37.8) | 26 (26.5) | 0.093 |
| Mediastinal re-explorationg | 69 (20) | 24 (20.5) | 0.92 | 20 (20.4) | 19 (19.4) | 0.86 |
| Hospital stay, days | 17.6 ± 22.6 | 18.7 ± 19.8 | 0.74 | 17.7 ± 14.6 | 17.3 ± 17.4 | 0.18 |
| Event . | Overall series . | PS-matched pairs . | ||||
|---|---|---|---|---|---|---|
| B-TVA (N = 345) . | R-TVA (N = 117) . | P-value . | B-TVA (N = 98) . | R-TVA (N = 98) . | P-value . | |
| In-hospital death | 26 (7.5) | 14 (12) | 0.14 | 5 (5.1) | 9 (9.2) | 0.27 |
| Stroke | 4 (1.2) | 0 | 0.36 | 3 (3.1) | 0 | 0.25 |
| Prolonged (>48 h) invasive ventilation | 64 (18.6) | 30 (25.6) | 0.1 | 18 (18.4) | 21 (21.4) | 0.59 |
| Atrial fibrillation, new-onset | 96/231c (41.6) | 21/86c (24.4) | 0.0049 | 25/66c (37.9) | 17/69c (24.6) | 0.097 |
| Transient complete atrioventricular block | 35/341d (10.3) | 20/116d (17.2) | 0.046 | 10/96d (10.4) | 14/97d (14.4) | 0.67 |
| Myocardial infarction | 1 (0.3) | 0 | 0.75 | 0 | 0 | – |
| Low cardiac outpute | 35 (10.1) | 21 (17.9) | 0.025 | 9 (9.2) | 14 (14.3) | 0.27 |
| Use of adrenergic agonists | 256 (74.2) | 91 (77.8) | 0.44 | 78 (79.6) | 73 (74.5) | 0.4 |
| Intra- and postoperative use of IABP | 7 (2) | 3 (2.6) | 0.49 | 0 | 1 (1) | 0.5 |
| Use of ECMO | 2 (0.6) | 0 | 0.56 | 0 | 0 | – |
| Acute kidney injuryf | 19 (5.5) | 12 (10.3) | 0.076 | 3 (3.1) | 7 (7.1) | 0.19 |
| Renal replacement therapy | 13 (3.8) | 8 (6.8) | 0.17 | 2 (2) | 5 (5.1) | 0.44 |
| Bleeding peptic ulcer | 1 (0.3) | 1 (0.9) | 0.44 | 0 | 0 | – |
| Mesenteric ischaemia | 3 (0.9) | 1 (0.9) | 0.73 | 1 (1) | 1 (1) | 1 |
| Acute pancreatitis | 0 | 1 (0.9) | 0.25 | 0 | 0 | – |
| Multiorgan failure | 22 (6.4) | 11 (9.4) | 0.27 | 4 (4.1) | 5 (5.1) | 1 |
| Sepsis | 8 (2.3) | 2 (1.7) | 0.51 | 1 (1) | 1 (1) | 1 |
| 48-h chest tube output, ml | 1371 ± 1510 | 1836 ± 2336 | 0.084 | 1412 ± 1552 | 1763 ± 2306 | 0.27 |
| Multiple blood transfusion (>2 RBCs) | 120 (34.8) | 33 (28.2) | 0.19 | 37 (37.8) | 26 (26.5) | 0.093 |
| Mediastinal re-explorationg | 69 (20) | 24 (20.5) | 0.92 | 20 (20.4) | 19 (19.4) | 0.86 |
| Hospital stay, days | 17.6 ± 22.6 | 18.7 ± 19.8 | 0.74 | 17.7 ± 14.6 | 17.3 ± 17.4 | 0.18 |
B-TVA: band tricuspid valve annuloplasty; ECMO: extracorporeal membrane oxygenator; HTK: histidine–tryptophan–ketoglutarate; IABP: intra-aortic balloon pumping; PS: propensity score; RBCs: packed red blood cells; R-TVA: ring tricuspid valve annuloplasty; SD: standard deviation.
aValues are the number of patients with percentages in brackets or mean ± SD.
bPerioperative data were compared using the χ2 or Fisher's exact test for dichotomous variables, and the Mann–Whitney U-test or Wilcoxon rank-sum test for continuous variables. The matched and unmatched patients were compared with the paired or unpaired test, respectively.
cPatients with preoperative stable sinus rhythm or paroxysmal atrial fibrillation.
dPatients without preoperative pacemaker.
eLow cardiac output was defined as three consecutive cardiac index measurements <2.0 l/min/m2 despite adequate preload, afterload and inotropic support or intra-aortic balloon pumping.
fPostoperative acute kidney injury was defined as postoperative serum creatinine >2.0 mg/l in the patients without preoperative renal impairment, and postoperative increase in serum creatinine of at least 1.0 mg/l above baseline in the patients with preoperative renal impairment.
gThrough resternotomy or subxyphoid window.
Hospital mortality, perioperative complications and hospital course of patients (N = 462)a,b
| Event . | Overall series . | PS-matched pairs . | ||||
|---|---|---|---|---|---|---|
| B-TVA (N = 345) . | R-TVA (N = 117) . | P-value . | B-TVA (N = 98) . | R-TVA (N = 98) . | P-value . | |
| In-hospital death | 26 (7.5) | 14 (12) | 0.14 | 5 (5.1) | 9 (9.2) | 0.27 |
| Stroke | 4 (1.2) | 0 | 0.36 | 3 (3.1) | 0 | 0.25 |
| Prolonged (>48 h) invasive ventilation | 64 (18.6) | 30 (25.6) | 0.1 | 18 (18.4) | 21 (21.4) | 0.59 |
| Atrial fibrillation, new-onset | 96/231c (41.6) | 21/86c (24.4) | 0.0049 | 25/66c (37.9) | 17/69c (24.6) | 0.097 |
| Transient complete atrioventricular block | 35/341d (10.3) | 20/116d (17.2) | 0.046 | 10/96d (10.4) | 14/97d (14.4) | 0.67 |
| Myocardial infarction | 1 (0.3) | 0 | 0.75 | 0 | 0 | – |
| Low cardiac outpute | 35 (10.1) | 21 (17.9) | 0.025 | 9 (9.2) | 14 (14.3) | 0.27 |
| Use of adrenergic agonists | 256 (74.2) | 91 (77.8) | 0.44 | 78 (79.6) | 73 (74.5) | 0.4 |
| Intra- and postoperative use of IABP | 7 (2) | 3 (2.6) | 0.49 | 0 | 1 (1) | 0.5 |
| Use of ECMO | 2 (0.6) | 0 | 0.56 | 0 | 0 | – |
| Acute kidney injuryf | 19 (5.5) | 12 (10.3) | 0.076 | 3 (3.1) | 7 (7.1) | 0.19 |
| Renal replacement therapy | 13 (3.8) | 8 (6.8) | 0.17 | 2 (2) | 5 (5.1) | 0.44 |
| Bleeding peptic ulcer | 1 (0.3) | 1 (0.9) | 0.44 | 0 | 0 | – |
| Mesenteric ischaemia | 3 (0.9) | 1 (0.9) | 0.73 | 1 (1) | 1 (1) | 1 |
| Acute pancreatitis | 0 | 1 (0.9) | 0.25 | 0 | 0 | – |
| Multiorgan failure | 22 (6.4) | 11 (9.4) | 0.27 | 4 (4.1) | 5 (5.1) | 1 |
| Sepsis | 8 (2.3) | 2 (1.7) | 0.51 | 1 (1) | 1 (1) | 1 |
| 48-h chest tube output, ml | 1371 ± 1510 | 1836 ± 2336 | 0.084 | 1412 ± 1552 | 1763 ± 2306 | 0.27 |
| Multiple blood transfusion (>2 RBCs) | 120 (34.8) | 33 (28.2) | 0.19 | 37 (37.8) | 26 (26.5) | 0.093 |
| Mediastinal re-explorationg | 69 (20) | 24 (20.5) | 0.92 | 20 (20.4) | 19 (19.4) | 0.86 |
| Hospital stay, days | 17.6 ± 22.6 | 18.7 ± 19.8 | 0.74 | 17.7 ± 14.6 | 17.3 ± 17.4 | 0.18 |
| Event . | Overall series . | PS-matched pairs . | ||||
|---|---|---|---|---|---|---|
| B-TVA (N = 345) . | R-TVA (N = 117) . | P-value . | B-TVA (N = 98) . | R-TVA (N = 98) . | P-value . | |
| In-hospital death | 26 (7.5) | 14 (12) | 0.14 | 5 (5.1) | 9 (9.2) | 0.27 |
| Stroke | 4 (1.2) | 0 | 0.36 | 3 (3.1) | 0 | 0.25 |
| Prolonged (>48 h) invasive ventilation | 64 (18.6) | 30 (25.6) | 0.1 | 18 (18.4) | 21 (21.4) | 0.59 |
| Atrial fibrillation, new-onset | 96/231c (41.6) | 21/86c (24.4) | 0.0049 | 25/66c (37.9) | 17/69c (24.6) | 0.097 |
| Transient complete atrioventricular block | 35/341d (10.3) | 20/116d (17.2) | 0.046 | 10/96d (10.4) | 14/97d (14.4) | 0.67 |
| Myocardial infarction | 1 (0.3) | 0 | 0.75 | 0 | 0 | – |
| Low cardiac outpute | 35 (10.1) | 21 (17.9) | 0.025 | 9 (9.2) | 14 (14.3) | 0.27 |
| Use of adrenergic agonists | 256 (74.2) | 91 (77.8) | 0.44 | 78 (79.6) | 73 (74.5) | 0.4 |
| Intra- and postoperative use of IABP | 7 (2) | 3 (2.6) | 0.49 | 0 | 1 (1) | 0.5 |
| Use of ECMO | 2 (0.6) | 0 | 0.56 | 0 | 0 | – |
| Acute kidney injuryf | 19 (5.5) | 12 (10.3) | 0.076 | 3 (3.1) | 7 (7.1) | 0.19 |
| Renal replacement therapy | 13 (3.8) | 8 (6.8) | 0.17 | 2 (2) | 5 (5.1) | 0.44 |
| Bleeding peptic ulcer | 1 (0.3) | 1 (0.9) | 0.44 | 0 | 0 | – |
| Mesenteric ischaemia | 3 (0.9) | 1 (0.9) | 0.73 | 1 (1) | 1 (1) | 1 |
| Acute pancreatitis | 0 | 1 (0.9) | 0.25 | 0 | 0 | – |
| Multiorgan failure | 22 (6.4) | 11 (9.4) | 0.27 | 4 (4.1) | 5 (5.1) | 1 |
| Sepsis | 8 (2.3) | 2 (1.7) | 0.51 | 1 (1) | 1 (1) | 1 |
| 48-h chest tube output, ml | 1371 ± 1510 | 1836 ± 2336 | 0.084 | 1412 ± 1552 | 1763 ± 2306 | 0.27 |
| Multiple blood transfusion (>2 RBCs) | 120 (34.8) | 33 (28.2) | 0.19 | 37 (37.8) | 26 (26.5) | 0.093 |
| Mediastinal re-explorationg | 69 (20) | 24 (20.5) | 0.92 | 20 (20.4) | 19 (19.4) | 0.86 |
| Hospital stay, days | 17.6 ± 22.6 | 18.7 ± 19.8 | 0.74 | 17.7 ± 14.6 | 17.3 ± 17.4 | 0.18 |
B-TVA: band tricuspid valve annuloplasty; ECMO: extracorporeal membrane oxygenator; HTK: histidine–tryptophan–ketoglutarate; IABP: intra-aortic balloon pumping; PS: propensity score; RBCs: packed red blood cells; R-TVA: ring tricuspid valve annuloplasty; SD: standard deviation.
aValues are the number of patients with percentages in brackets or mean ± SD.
bPerioperative data were compared using the χ2 or Fisher's exact test for dichotomous variables, and the Mann–Whitney U-test or Wilcoxon rank-sum test for continuous variables. The matched and unmatched patients were compared with the paired or unpaired test, respectively.
cPatients with preoperative stable sinus rhythm or paroxysmal atrial fibrillation.
dPatients without preoperative pacemaker.
eLow cardiac output was defined as three consecutive cardiac index measurements <2.0 l/min/m2 despite adequate preload, afterload and inotropic support or intra-aortic balloon pumping.
fPostoperative acute kidney injury was defined as postoperative serum creatinine >2.0 mg/l in the patients without preoperative renal impairment, and postoperative increase in serum creatinine of at least 1.0 mg/l above baseline in the patients with preoperative renal impairment.
gThrough resternotomy or subxyphoid window.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
